-
Why Drug Prices Are Unnecessarily High
The root problem in our drug pricing system isn’t just high prices—it’s how those prices are set. In a normal market, buyers and sellers see the price and make decisions accordingly. But in pharmaceuticals, the system is built on information hiding and artificial scarcity. LIST PRICES AREN’T REAL Manufacturers set list prices arbitrarily high, but…
-
Georgia’s Strategy to Combat the Opioid Crisis
The federal government has failed to prioritize the development of a non-addictive opioid replacement. Research is scattered, underfunded, and bogged down by bureaucracy. Meanwhile, the opioid crisis continues to cost the U.S. $1.5 trillion per year, with fentanyl smuggling fueling a deadly addiction cycle. Georgia has a unique opportunity to change the trajectory of this…
-
Investing in Non-Addictive Painkillers: A Solution to the Fentanyl Crisis
A Smarter Alternative to Tariffs: Investing in Non-Addictive Painkillers to Undermine the Fentanyl Trade Tariffs on Mexico and Canada are being discussed as a way to pressure their governments into taking stronger action against fentanyl smuggling. While this approach may seem like a tough stance, it could have unintended consequences—crippling legitimate economies, reducing enforcement funding,…
-
Fixing Costs, Not Just Cutting Them: A Smarter Approach to Reduced Spending
Cost-cutting is not a plan—it’s a reaction. It often ignores the fact that spending exists to solve a real problem. The policy in place may be expensive and ineffective, but simply cutting or trimming it doesn’t make the problem go away—it just ensures we’ll solve it badly again in the future. The real issue isn’t…